Dexcom for Medicare
According to the Centers for Medicare and Medicaid Services, Medicare may cover therapeutic CGM when:
-
The beneficiary has diabetes mellitus
-
The beneficiary has been testing four or more times a day
-
The beneficiary uses three or more multiple daily injections (MDI) or a pump
-
The treatment regimen requires the beneficiary to frequently adjust based on the therapeutic CGM testing results
-
The beneficiary has seen his/her doctor in the last six months
To remain eligible, the beneficiary must see his/her doctor every six months to evaluate the CGM therapy.
*In order to qualify for Medicare coverage of your Dexcom G6 system, Medicare requires that you have a receiver that is compatible with Dexcom G6 and that you use that receiver with your supplies, even if you also use a compatible smart device. Medicare does not cover Dexcom G6 supplies that are only used with a smartphone or other mobile device. To view a list of compatible smart devices, visit dexcom.com/compatibility
Dexcom G6® Therapeutic CGM System
Dexcom G6 Therapeutic Continuous Glucose Monitoring System allows you to monitor your glucose number and know where it’s headed. Now available for Medicare, the Dexcom G6 system:
-
Displays real-time glucose readings, right on your receiver or smart device* (phone, watch, tablet, etc.)
-
Enables you to know your glucose number and where it’s headed with zero fingersticks and no calibration
-
Has unique sharing capabilities and alerts that are customizable for you
-
Features a slim, water-resistant sensor with an extended 10-day wear offering more convenience and fewer interruptions
-
Is proven to lower A1C and reduce hypoglycemic incidents
